Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmaceutical industry’s policy proposals set sights on non-communicable diseases

This article was originally published in Scrip

Executive Summary

Behind the scenes over the last ten years, the pharmaceutical industry has been going through some important changes in how it responds to the need for medicines and vaccines in developing countries. The AIDS epidemic in many developing countries was the tipping point and set the changes in motion. Now, the global health community faces a different, but just as challenging a task: to address the mounting threats of cardiovascular diseases, diabetes, cancers, and chronic respiratory diseases (collectively called “non-communicable diseases”, or NCDs). Today, the pharmaceutical industry is ready to respond to calls for action and will announce at the United Nations (UN) in New York a Framework for Action for the prevention and control of non-communicable diseases.

Topics

Related Companies

UsernamePublicRestriction

Register

SC013325

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel